Literature DB >> 6767548

Different lymphoid cell targets by transformation by replication-competent Moloney and Rauscher mouse leukemia viruses.

E P Reddy, C Y Dunn, S A Aaronson.   

Abstract

Mouse leukemia viruses (MuLV) have been reported to induce tumors involving cells within the T lymphocyte lineage. In the present study, striking differences were demonstrated in the target cells for in vivo transformation by two clonal replication-competent type C viruses, Moloney- and Rauscher-MuLV. Moloney-MuLV-induced tumors and lymphoma cell lines exhibited Thy.1 antigen in the absence of detectable Fc or C3 receptors, indicating their T cell origin. Rauscher-MuLV primary tumors and lymphoma cell lines of the same mouse strain, however, invariably exhibited Fc receptors in the absence of Thy.1 antigen, suggesting that these tumors were of the B lymphoid lineage. The pattern of immunoglobulin synthesis by individual Rauscher-MuLV tumor cell lines was determined by both biosynthetic and radioimmunologic techniques. Rauscher-MuLV lymphoma lines invariably expressed immunoglobulin heavy (mu) chain in the absence of detectable light (kappa or lambda) chains. These findings establish that the target of neoplastic transformation in response to Rauscher-MuLV is an immature cell within the B lymphoid lineage. The demonstration of different target cells for transformation by well characterized clonal strains of mouse leukemia virus should aid in elucidating the mechanisms by which these viruses induce malignancy.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6767548     DOI: 10.1016/s0092-8674(80)80043-2

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  18 in total

1.  Members of the src and ras oncogene families supplant the epidermal growth factor requirement of BALB/MK-2 keratinocytes and induce distinct alterations in their terminal differentiation program.

Authors:  B Weissman; S A Aaronson
Journal:  Mol Cell Biol       Date:  1985-12       Impact factor: 4.272

2.  Rauscher murine leukemia virus: molecular cloning of infectious integrated proviral DNA.

Authors:  A Habara; E P Reddy; S A Aaronson
Journal:  J Virol       Date:  1982-11       Impact factor: 5.103

3.  Myeloid cell transformation by ras-containing murine sarcoma viruses.

Authors:  J H Pierce; S A Aaronson
Journal:  Mol Cell Biol       Date:  1985-04       Impact factor: 4.272

4.  Generation and characterization of a recombinant Moloney murine leukemia virus containing the v-myc oncogene of avian MC29 virus: in vitro transformation and in vivo pathogenesis.

Authors:  B K Brightman; P K Pattengale; H Fan
Journal:  J Virol       Date:  1986-10       Impact factor: 5.103

5.  Recombinant murine retroviruses containing avian v-myc induce a wide spectrum of neoplasms in newborn mice.

Authors:  H C Morse; J W Hartley; T N Fredrickson; R A Yetter; C Majumdar; J L Cleveland; U R Rapp
Journal:  Proc Natl Acad Sci U S A       Date:  1986-09       Impact factor: 11.205

6.  Hematopoietic cell transformation by a murine recombinant retrovirus containing the src gene of Rous sarcoma virus.

Authors:  J H Pierce; S A Aaronson; S M Anderson
Journal:  Proc Natl Acad Sci U S A       Date:  1984-04       Impact factor: 11.205

7.  T and B lymphocyte susceptibility to murine leukemia virus moloney.

Authors:  D D Isaak; J Cerny
Journal:  Infect Immun       Date:  1983-06       Impact factor: 3.441

8.  Effects of nonleukemogenic and wild-type Moloney murine leukemia virus on lymphoid cells in vivo: identification of a preleukemic shift in thymocyte subpopulations.

Authors:  B R Davis; K G Chandy; B K Brightman; S Gupta; H Fan
Journal:  J Virol       Date:  1986-11       Impact factor: 5.103

9.  Moloney murine leukemia virus-induced tumors: recombinant proviruses in active chromatin regions.

Authors:  H van der Putten; W Quint; I M Verma; A Berns
Journal:  Nucleic Acids Res       Date:  1982-01-22       Impact factor: 16.971

10.  Immunopathology of natural and experimental lymphomas induced by wild mouse leukemia virus.

Authors:  M L Bryant; J L Scott; B K Pal; J D Estes; M B Gardner
Journal:  Am J Pathol       Date:  1981-09       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.